Co-founder & CEO, Bio-Modeling Systems,
Vice-President, Innovation, Adebiotech
Manuel Gea, 50 years old, has a long experience in innovation and business. Is Co-founder & C.E.O & VP R&D Information Systems Bio-Modeling Systems, President of the Supervisory board of Pherecydes Pharma and founding-Administrator of the computing firm Formitel.
Previously to his current positions, Manuel Gea served as CEO of Hemispherx Biopharma Europe, McKinsey executive, creator of Practice Pharma services in France, division Managing Director with Boehringer-Ingelheim France, international business manager Colgate-Palmolive Company (US), and product manager and Industrial/logistic manager Colgate-Palmolive France,
Manuel Gea's main domain of interest is focused on how to create and sustain the best environment to generate and develop disruptive innovations in the field of life sciences.
He is founder and President of Centrale-Santé; co-founder and Vice President of the Biotech Committee of the Pharma industry association in France (Leem); member of the R&D committee and executive board of Medicen Paris-Region; the World class biocluster of Paris region; vice-president Adebiotech; co-founder and committee member of Paris Biotech (leading biotech incubator). Member of BiO US; co-leader of the Prospective group of the MEDEF (French Business Confederation) life sciences and healthcare committee.
Because any vision needs proof of concept to be valid, a group of scientist, met inside Centrale-Santé Think Tank, created in 2004 Bio-Modeling Systems, the first company applying their disruptive innovation principles. Today their company, a leading integrative systems biology company that delivers is recognized as a successful pioneer in terms of research and business model and has already created disruptive innovative spin-offs form his research.
- How to better generate & sustain disruptive innovation for SMEs? ( 430 KB)
The healthcare sector is facing, despite massive investments in R&D, a major crisis of innovation that now clearly creates a long run sustainable issue for the industry. The problem may came from a wrong answer to a good question: How to increase the success rate of the industry ?
The objective of the talk is to explain through examples the founding misunderstanding of the nature of mechanisms of life, and the limitations of the current "Cartesian" answers to unsuccessfully solve the issue and to explain how to change the rules of the game and how to create the specific environment for disruptive innovators, generally strange "non-opinion leaders" academics and SMEs founders, to have a chance to implement their "strange" approaches against "all" the experts. Discussion with the participant will promoted to get feed back and possible best practice.